[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,623
  • Shares Outstanding, K 62,843
  • Annual Sales, $ 37,060 K
  • Annual Income, $ -8,200 K
  • EBIT $ -13 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.39
  • Price/Sales 0.61
  • Price/Cash Flow N/A
  • Price/Book 10.33
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings $-0.08 on 05/13/26
  • Next Earnings Date 08/06/26 [AMC]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Options Overview Details

View History
  • Implied Volatility 668.79% (+218.33%)
  • Historical Volatility 115.47%
  • IV Percentile 85%
  • IV Rank 51.24%
  • IV High 1,215.56% on 12/02/25
  • IV Low 94.16% on 03/16/26
  • Expected Move (DTE 25) 1.7935 (498.19%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 370
  • Open Int (30-Day) 476
  • Expected Range 0.0000 to 2.1535

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 2
  • High Estimate $-0.04
  • Low Estimate $-0.05
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3500 +2.86%
on 07/17/26
0.4601 -21.76%
on 07/06/26
-0.0020 (-0.55%)
since 06/26/26
3-Month
0.3500 +2.86%
on 07/17/26
0.6499 -44.61%
on 05/04/26
-0.2520 (-41.18%)
since 04/27/26
52-Week
0.3500 +2.86%
on 07/17/26
1.2200 -70.49%
on 08/11/25
-0.5836 (-61.85%)
since 07/25/25

Most Recent Stories

More News
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights

PRINCETON, N.J. , July 20, 2026 /PRNewswire/ -- CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.3600 (unch)
CytoSorbents: Q1 Earnings Snapshot

CytoSorbents: Q1 Earnings Snapshot

CTSO : 0.3600 (unch)
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

PRINCETON, N.J. , May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.3600 (unch)
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

PRINCETON, N.J. , April 30, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.3600 (unch)
CytoSorbents: Q4 Earnings Snapshot

CytoSorbents: Q4 Earnings Snapshot

CTSO : 0.3600 (unch)
CytoSorbents Announces HotSwapâ„¢ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

PRINCETON, N.J. , March 19, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...

CTSO : 0.3600 (unch)
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

PRINCETON, N.J. , March 5, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.3600 (unch)
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

Fourth quarter and Full-Year 2025 revenue are expected to be approximately   $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range of 73% to 75%

CTSO : 0.3600 (unch)
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025

PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.3600 (unch)
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 0.3600 (unch)

Business Summary

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product...

See More

Key Turning Points

3rd Resistance Point 0.4141
2nd Resistance Point 0.3993
1st Resistance Point 0.3797
Last Price 0.3600
1st Support Level 0.3453
2nd Support Level 0.3305
3rd Support Level 0.3109

See More

52-Week High 1.2200
Fibonacci 61.8% 0.8877
Fibonacci 50% 0.7850
Fibonacci 38.2% 0.6823
Last Price 0.3600
52-Week Low 0.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.